Cited 24 time in
Cell-penetrating peptide-based non-invasive topical delivery systems
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Van, Nguyen T. | - |
| dc.contributor.author | Shin, M.C. | - |
| dc.contributor.author | Min, K.A. | - |
| dc.contributor.author | Huang, Y. | - |
| dc.contributor.author | Oh, E. | - |
| dc.contributor.author | Moon, C. | - |
| dc.date.accessioned | 2022-12-26T18:03:49Z | - |
| dc.date.available | 2022-12-26T18:03:49Z | - |
| dc.date.issued | 2018 | - |
| dc.identifier.issn | 2093-5552 | - |
| dc.identifier.issn | 2093-6214 | - |
| dc.identifier.uri | https://scholarworks.gnu.ac.kr/handle/sw.gnu/13006 | - |
| dc.description.abstract | Cell-penetrating peptides (CPPs) have been receiving much attention over the last few decades due to their unique ability to translocate across plasma membranes efficiently and carry the wide range of macromolecular cargoes with them. Although their intracellular delivery mechanism has not been fully elucidated, CPP-based cellular uptake, mainly mediated by direct transduction or endocytosis, depends on structural characteristics of CPPs, the type and concentration of CPPs or cargoes, and cell types being treated. To overcome the intrinsic drawbacks of CPPs including lack of cell or tissue specificity, short plasma half-life, and endosomal sequestration, various strategies have been suggested such as activatable CPPs (ACPPs), introduction of targeting moieties and fusion peptides, and topical delivery systems for clinical application. In this review, we provide an overview of up-to-date knowledge of intracellular delivery mechanisms of CPPs and introduce potential topical applications of CPPs such as transdermal, nasal and ocular delivery for non-invasive delivering the therapeutic proteins or peptides. ? 2017, The Korean Society of Pharmaceutical Sciences and Technology. | - |
| dc.format.extent | 11 | - |
| dc.language | 영어 | - |
| dc.language.iso | ENG | - |
| dc.publisher | Springer Netherlands | - |
| dc.title | Cell-penetrating peptide-based non-invasive topical delivery systems | - |
| dc.type | Article | - |
| dc.publisher.location | 대한민국 | - |
| dc.identifier.doi | 10.1007/s40005-017-0373-1 | - |
| dc.identifier.scopusid | 2-s2.0-85040240932 | - |
| dc.identifier.bibliographicCitation | Journal of Pharmaceutical Investigation, v.48, no.1, pp 77 - 87 | - |
| dc.citation.title | Journal of Pharmaceutical Investigation | - |
| dc.citation.volume | 48 | - |
| dc.citation.number | 1 | - |
| dc.citation.startPage | 77 | - |
| dc.citation.endPage | 87 | - |
| dc.type.docType | Review | - |
| dc.identifier.kciid | ART002310810 | - |
| dc.description.isOpenAccess | N | - |
| dc.description.journalRegisteredClass | scopus | - |
| dc.description.journalRegisteredClass | kci | - |
| dc.subject.keywordAuthor | Cell-penetrating peptides | - |
| dc.subject.keywordAuthor | Intracellular delivery | - |
| dc.subject.keywordAuthor | Ocular delivery | - |
| dc.subject.keywordAuthor | Protein delivery | - |
| dc.subject.keywordAuthor | Topical delivery | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
Gyeongsang National University Central Library, 501, Jinju-daero, Jinju-si, Gyeongsangnam-do, 52828, Republic of Korea+82-55-772-0532
COPYRIGHT 2022 GYEONGSANG NATIONAL UNIVERSITY LIBRARY. ALL RIGHTS RESERVED.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.
